Fulgent Genetics, Inc. SEC filings FLGT
Fulgent Genetics, Inc. has 670 filings in SEC EDGAR's recent list, going back to Jun 9, 2016. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 31, 2026 | — |
| DEF 14A | Proxy statement | Mar 31, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Mar 26, 2025 | — |
| DEF 14A | Proxy statement | Mar 25, 2025 | Mar 25, 2025 |
| DEFA14A | Additional proxy material | Mar 27, 2024 | — |
| DEF 14A | Proxy statement | Mar 27, 2024 | Mar 27, 2024 |
| DEFA14A | Additional proxy material | Apr 3, 2023 | — |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 29, 2022 | May 18, 2022 |
| DEFA14A | Additional proxy material | Apr 1, 2021 | — |
| DEF 14A | Proxy statement | Apr 1, 2021 | May 20, 2021 |
| DEF 14A | Proxy statement | Aug 31, 2020 | Sep 17, 2020 |
| PRE 14A | Preliminary proxy statement | Aug 21, 2020 | Sep 17, 2020 |
| DEF 14A | Proxy statement | Apr 17, 2020 | May 27, 2020 |
| DEF 14A | Proxy statement | Apr 17, 2019 | May 30, 2019 |
| DEF 14A | Proxy statement | Apr 13, 2018 | May 18, 2018 |
| DEF 14A | Proxy statement | Apr 10, 2017 | May 16, 2017 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2017 | May 16, 2017 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- FLGT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- El Monte, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1674930
- Former names
- Fulgent Diagnostics, Inc. (until Jul 15, 2016)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.